Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease

Autor:	Yu. V. Kotlovsky, D. A. Kirichenko, K. V. Zlodeyev, M. Yu. Kotlovsky, V. A. Shulman, S. V. Klemenkov, R. S. Karpov, Ye. N. Ivtchenko, S. Yu. Nikulina, A. A. Masterova, S. V. Mashkovskaya, O. V. Voronkova, V. V. Novitsky
Rok vydání:	2008
Předmět:	ischemia heart disease medicine.medical_specialty Heart disease business.industry Ischemia medicine.disease Simvastatin Internal medicine Blood plasma medicine Cardiology simvastatin Medicine Molecular Medicine fat acids business medicine.drug
Zdroj:	Bûlleten' Sibirskoj Mediciny, Vol 7, Iss 3, Pp 13-19 (2008)
ISSN:	1819-3684 1682-0363
Popis:	The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc6023a18853c68ccd2c6dabb655542 https://doi.org/10.20538/1682-0363-2008-3-13-19 Zobrazit plný text záznamu